Close Menu

NEW YORK (GenomeWeb) — Canine consumer genomics firm Embark Veterinary said today that it has closed a $10 million Series A financing round.

The round was led by F-Prime Capital and included existing investors Slow Ventures, Section 32, Third Kind Venture Capital, Freestyle Capital, FJ Labs, and 23andMe CEO Anne Wojcicki. It follows a $4.5 million funding round in mid-2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.